Dr. Vincent Lombardi, the primary investigator and first author on a paper that appeared in the 8 October 2009 issue of “Science”, is the Director of Operations for the licensing and development of the XAND test assays used by VIP Dx for the detection of XMRV.
To read this landmark publication, "Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome", please go to (www.sciencemag.org).
We are pleased to announce that VIP Dx has licensed this technology allowing us to offer the most accurate and sensitive testing available for XAND (XMRV associated neuro-immune disease).
TO ORDER XAND TEST KITS, CONTACT VIP Dx.
To learn more about our XMRV tests,
CLICK HERE.
To read this landmark publication, "Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome", please go to (www.sciencemag.org).
We are pleased to announce that VIP Dx has licensed this technology allowing us to offer the most accurate and sensitive testing available for XAND (XMRV associated neuro-immune disease).
TO ORDER XAND TEST KITS, CONTACT VIP Dx.
To learn more about our XMRV tests,
CLICK HERE.
CAVEAT EMPTOR
ReplyDelete*" The XAND tests were developed and their performance characteristics were determined and validated by VIP Dx. These tests have not been approved by the U.S. Food and Drug Administration (FDA) for diagnostic purposes. Medical expertise is required for XAND test interpretation."